CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 45 enrolled
Drug / intervention
F&P Carameldevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06060717
NCT06060717N/ACompleted

Evaluation of the F&P Caramel Nasal Mask, US, 2023

Fisher and Paykel Healthcare·interventional·Posted Sep 29, 2023·Updated Sep 23, 2025

In Brief

A clinical study evaluating F&P Caramel for Obstructive Sleep Apnea. Completed, enrolled 45 participants across 1 site.

Detailed Summary

The purpose of this clinical investigation is to evaluate the performance and safety of the F\&P Caramel nasal mask in a home environment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedSep 29, 2023
Enrollment StartNov 27, 2023
Primary CompletionDec 11, 2023
Study CompletionJun 11, 2024
TodayJul 2, 2026
Enrollment to primary: 14 daysPosted 2.8 years ago

Interventions

F&P Carameldevice

Nasal mask